NOVARTIS FDA Approval ANDA 062544

ANDA 062544

NOVARTIS

FDA Drug Application

Application #062544

Application Sponsors

ANDA 062544NOVARTIS

Marketing Status

Discontinued001

Application Products

001SUSPENSION/DROPS;OPHTHALMIC0.1%;EQ 3.5MG BASE/ML;10,000 UNITS/ML0DEXACIDINDEXAMETHASONE; NEOMYCIN SULFATE; POLYMYXIN B SULFATE

FDA Submissions

ORIG1AP1984-10-29
MANUF (CMC); Manufacturing (CMC)SUPPL2AP1993-01-04
LABELING; LabelingSUPPL3AP1993-08-17
MANUF (CMC); Manufacturing (CMC)SUPPL4AP1995-04-24
MANUF (CMC); Manufacturing (CMC)SUPPL5AP1994-06-10
MANUF (CMC); Manufacturing (CMC)SUPPL6AP1998-02-11
MANUF (CMC); Manufacturing (CMC)SUPPL9AP2001-04-19

Submissions Property Types

ORIG1Null0
SUPPL2Null0
SUPPL3Null0
SUPPL4Null0
SUPPL5Null0
SUPPL6Null0
SUPPL9Null0

CDER Filings

cder:Array
(
    [0] => Array
        (
            [ApplNo] => 62544
            [companyName] => 
            [docInserts] => ["",""]
            [products] => []
            [labels] => 
            [originalApprovals] => []
            [supplements] => 
            [actionDate] => 0000-00-00
        )

)

© 2026 FDA.report
This site is not affiliated with or endorsed by the FDA.